Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
ImmunityBio, Inc. Common Stock
IPO Date: July 27, 2015
Sector: Healthcare
Industry: Biotech
Market Cap: $2.4B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.26 | 4.57%
Avg Daily Range (30 D): $0.08 | 2.72%
Avg Daily Range (90 D): $0.09 | 3.38%
Institutional Daily Volume
Avg Daily Volume: 3.29M
Avg Daily Volume (30 D): 8.06M
Avg Daily Volume (90 D): 7.56M
Trade Size
Avg Trade Size (Sh.): 203
Avg Trade Size (Sh.) (30 D): 383
Avg Trade Size (Sh.) (90 D): 348
Institutional Trades
Total Inst.Trades: 1,130
Avg Inst. Trade: $1.84M
Avg Inst. Trade (30 D): $1.97M
Avg Inst. Trade (90 D): $1.56M
Avg Inst. Trade Volume: .34M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.94M
Avg Closing Trade (30 D): $1.63M
Avg Closing Trade (90 D): $1.42M
Avg Closing Volume: 351.94K
   
News
Jul 9, 2025 @ 12:30 PM
Breaking Through: Systemic Genetic Medicines for H...
Source: Prnewswire
Aug 23, 2024 @ 8:30 PM
HCW Biologics Reports Second Quarter 2024 Financia...
Source: N/A
Jun 26, 2024 @ 1:41 PM
ImmunityBio (IBRX) Gains 17% in the Past Week: Her...
Source: Zacks Equity Research
Mar 20, 2024 @ 3:41 PM
Sportradar Group Posts Upbeat Earnings, Joins King...
Source: Avi Kapoor
Feb 26, 2024 @ 6:57 PM
Why Freshpet Shares Are Trading Higher By Around 1...
Source: Avi Kapoor
Financials
  TTM Q3 2024 Q2 2024
Basic EPS $-.15 $-.12 $-.2
Diluted EPS $-.15 $-.14 $-.2
Revenue $ 16.52M $ 6.11M $ 1.05M
Gross Profit $ 16.46M $ $
Net Income / Loss $ -129.67M $ -85.75M $ -134.58M
Operating Income / Loss $ -64.43M $ -80.25M $ -99.33M
Cost of Revenue $ .06M $ M $ M
Net Cash Flow $ -82.76M $ -18.15M $ -2.94M
PE Ratio